NSI 5-Loxin®-AKBA Boswellia Serrata Extract -- 150 mg per serving -120 Capsules

NSI® 5-LOXIN® 150 mg, 120 caps supports bone health. It may help protect joint cartilage and tissues. How does NSI® 5-LOXIN® 150 mg work? This new, patent-pending dietary supplement inhibits an enzyme called 5-lipoxygenase. 5-LOX inhibitors do not produce the same potentially negative effects associated with COX-2 inhibitors. 5-LOXIN® is a selective inhibitor. Its actions are very targeted and do not effect other systems. 5-LOXIN® is a standardized extract of boswellia serrata, providing 30% acetyl-11-keto-beta boswellic acid (AKBA). AKBA has been identified as the most potent of all boswellic acids. And while other extracts contain 2 to 3% AKBA, the patented process for creating 5-LOXIN® results in a standardized 30% AKBA extract, the highest concentration available. 5-LOXIN® protects joint cartilage and tissues by inhibiting production of matrix metalloproteinase (MMP) – enzymes that selectively destroy peptide bonds and structural proteins. 5-LOXIN® helps inhibit collagen degradation, supporting bone and joint health. NSI® 5-LOXIN® 150 mg is better because:. -- It offers the highest available concentration of AKBA extract (30%). -- Its actions are very targeted. -- It supports bone and joint health. Did You Know? All NSI supplements are packaged in HDPE (High Density Polyethylene) bottles. These bottles keep moisture vapor out, protecting the freshness and integrity of their contents, and are 400% more effective compared other brands currently using PET (Polyethylene Terephthalate) bottles. HDPE bottles do not break as glass can and are also recyclable so we urge you to please recycle them.

Average Customer Rating: 4.3 out of 5

12 of 12 (100%) customers would recommend this product to a friend.